121P Double lung transplantation (DLT) in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series

patients (62.0%) considered the DDI tool to be "relevant" or "extremely relevant" to their specific situation.72 patients (78.2%) anticipated using the tool to check for DDIs, and 62 patients (67.4%) expected to discuss the results with their health care providers. Conclusions:Patients with lung cancer visiting a private ALK+ Facebook Support Group have a high likelihood of experiencing a DDI between their lung cancer treatment and other medications.Our survey indicates that patients can be empowered to use a dedicated expert-based DDI tool to get insights into potential interactions.